All News

This is a nice study but does not address effects on CRITICAL and PATHOGENIC autoantibody production- Prosepctive studies are urgently needed in SLE and AAV among others @GSKUS @Lupusdoc @LupusOrg @LupusResearch @RheumNow @HealioRheum @CCalabreseDO #shingles https://t.co/7yhHmQfphY

Links:

Leonard Calabrese LCalabreseDO ( View Tweet)

Sorry to have missed this critical session - but feeling better- Closing the gap between pateint and provider is the new horizon in well being as opposed to health All reports of #EULAR2019 are terrific and following on @RheumNow #empathy https://t.co/DUhlRMtrDX

Links:

Leonard Calabrese LCalabreseDO ( View Tweet)

Analysis from the BSRBR ankylosing spondylitis registry of 2420 AS pts shows that HLA-B27 is associated with an increased risk of anterior uveitis but a decreased risk of psoriasis and IBD. #Eular2019 OP0262 https://t.co/jslLYkMr9Q
Dr. John Cush RheumNow ( View Tweet)
Do you stop #methotrexate in your male patients who wish to conceive? No need to do so according to studies from the past few years: no increase in adverse pregnancy outcomes if paternal exposure. Prof. Monika Ostensen at #EULAR2019 >LA

ARD & RMD Open ARD_BMJ ( View Tweet)

Gr8. Tocilizumab in GCA - data we’ve been waiting to see RT @chechitap: #EULAR2019 giacta long term https://t.co/UEFX4fY3Nw
Dr Irwin Lim _connectedcare ( View Tweet)
Shingrix can be give to inflammatory arthritis pts? Collective report from the Brigham & Women’s Hospital looked at the safety of Shingrix given to 300 RA, PsA, etc patient without any reports of H.Zoster and a 4% rate of "flares". #EULAR2019 FRI0068 https://t.co/Wkx5V9vM8r https://t.co/kErMMU97tB

Links:

Dr. John Cush RheumNow ( View Tweet)
What’s next in biosimilars? Visit RheumNow to listen to experts discuss this and more in "Therapeutic Update: Biosimilars in Rheumatology," a video series sponsored by Sandoz, Inc. https://t.co/1vmnEJqOSi #sponsored #biosimilars

Links:

Dr. John Cush RheumNow ( View Tweet)

Very interesting. Another strike against steroids...? https://t.co/LGz7fKh9hU

Links:

Paul Sufka, MD psufka ( View Tweet)

Updated treatment algorithm for extrarenal #Lupus 👉🏻 MSK 👉🏻 Skin 👉🏻 Hematological 👉🏻 Cardiovascular 👉🏻 Lung 👉🏻Serositis 👉🏻 Vasculitis #EULAR2019 https://t.co/LDr0hKZAfV
Juan Ovalles, MD, PhD DrJuanOvalles ( View Tweet)
JAK system really important for many bodily functions. So the aim is to “turn down the thermostat” without “turning it off” Ernest Choy #EULAR2019 https://t.co/863ktP3CIg
Dr Irwin Lim _connectedcare ( View Tweet)
#EULAR2019 session ‘Getting A Grip on The Comorbidities in Gout’ focused on the complex and variable disease profile patients experience and clinicians treat. Do #gout co-morbidities occur in patterns? Dr Ed Roddy discusses. Abstract SP0061 @RheumNow https://t.co/EHoNdP7iMo
Gout Study Group GoutGroup ( View Tweet)
Baracitinib affects JAK2 more than Tofacitinib. Difference can be seen with lower Hb & higher platelets #EULAR2019 https://t.co/BfzuyZI8f9
Dr Irwin Lim _connectedcare ( View Tweet)
JAKi also helps reduce bone loss #EULAR2019 https://t.co/8JOUp3aJWQ
Dr Irwin Lim _connectedcare ( View Tweet)
This graph is a reminder that over time, the level of Inflammation in RA may reduce with lower symptoms. However, CUMULATIVE inflam leads to increasing damage & disability #EULAR2019 https://t.co/ujhODMOp4E
Dr Irwin Lim _connectedcare ( View Tweet)
Look at the difference in patient reported outcome measures. Baracitinib vs Adalimumab #EULAR2019 https://t.co/xrQDdKIspV
Dr Irwin Lim _connectedcare ( View Tweet)
Risk factors for #sarcopenia in #rheumatoid arthritis 👉🏼Male 👉🏼Old age 👉🏼Glucocorticoid 👉🏼Increased MMP3 👉🏼Increased HAQ #EULAR2019 THU0159 #muscle #RheumatoidArthritis https://t.co/Fn1SvCapqm
Dr Ai Lyn Tan DrAiLynTan ( View Tweet)
patients are lucky to have docs like @DrHillaryNorton sharing these #arthritis #breakthroughs #EULAR2019 https://t.co/nQg1WIFD4c

Links:

CreakyJoints.org CreakyJoints ( View Tweet)

Optimizing ➡️#weight ➡️sleep ➡️physical #health ➡️emotional health ➡️MTX use 👉🏼may improve persistent #fatigue beyond control of #rheumatoid inflammation via @Susanbartlett12 #EULAR2019 #obesity https://t.co/vuMNWazloo
Dr Ai Lyn Tan DrAiLynTan ( View Tweet)
TNF inhibitors vs JAK inhibitors: what’s the head-to-head study state of play? (**efficacy not safety, non-real life data of course) #EULAR2019 Gerd Burmester on ‘The wind of change in RA’ @RheumNow https://t.co/zK1wqskmLc
David Liew drdavidliew ( View Tweet)
AE in SENCIS data. #EULAR2019 Ofev had higher discontinuation due to medication and higher GI associated illness in the trial. https://t.co/0E21Z4B8TU
Dr. Dinesh Khanna sclerodermaUM ( View Tweet)
×